1. Home
  2. AGIG vs NSPR Comparison

AGIG vs NSPR Comparison

Compare AGIG & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abundia Global Impact Group Inc. Common stock

AGIG

Abundia Global Impact Group Inc. Common stock

N/A

Current Price

$1.03

Market Cap

41.8M

Sector

Energy

ML Signal

N/A

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.72

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIG
NSPR
Founded
N/A
2005
Country
United States
United States
Employees
2
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.8M
33.7M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
AGIG
NSPR
Price
$1.03
$0.72
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
130.1K
85.7K
Earning Date
05-19-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,310,000.00
Revenue This Year
N/A
$57.98
Revenue Next Year
N/A
$95.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$0.63
52 Week High
$5.31
$2.93

Technical Indicators

Market Signals
Indicator
AGIG
NSPR
Relative Strength Index (RSI) 49.96 39.18
Support Level $0.92 $0.69
Resistance Level $1.26 $1.04
Average True Range (ATR) 0.08 0.04
MACD 0.01 0.02
Stochastic Oscillator 77.08 70.10

Price Performance

Historical Comparison
AGIG
NSPR

About AGIG Abundia Global Impact Group Inc. Common stock

Abundia Global Impact Group Inc. is a technology solutions company operating in recycling, renewable energy, environmental change, fuels, and chemicals sectors, mainly focused on low-carbon energy solutions. The company uses waste plastics and biomass to produce crude or drop-in alternatives to fossil-derived energy, fuels, and chemicals through proprietary, licensed, and commercialized technologies, forming a complete process. It operates through its subsidiary and integrates feedstocks, technology, and off-take partners into a complete commercial chain. Its segments include Oil and Gas (O&G), which generates maximum revenue, and Renewables, which consists of its low-carbon fuels and renewable chemicals business.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: